FIELD: medicine.
SUBSTANCE: group of inventions refers to agents for preventing and treating arthropathies containing a mixture of peptides H-Ala-Glu-Asp-OH, Lys-Glu-Asp and H-Lys-Glu-OH and a mixture of chondroitin and/or its salts, and/or glucosamines and/or its salts; methods for using them. The group of inventions provides a positive variation of clinical-biochemical dynamics. What is also provided is normalising the morphological structure of joint tissues, including a cytoarchitectonic characteristic of cartilaginous tissue with decreasing apoptotic chondrocyte count, especially at the final stages.
EFFECT: provided favourable effect on the metabolic processes in chondrocytes, activated synthetic processes and normalised biopolymer composition of the cartilage matrix An evident analgesic effect is manifested.
20 cl, 5 ex, 5 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION, AGENT (VERSIONS) AND METHOD OF PREVENTING AND TREATING ARTHRITIS, OSTEOARTHROSIS AND VERTEBRAL OSTEOCHONDROSIS (VERSIONS) | 2012 | 
 | RU2496511C1 | 
| PREPARATION WITH CHONDROPROTECTIVE AND ANTI-INFLAMMATORY EFFECT | 2024 | 
 | RU2832653C1 | 
| AGENT FOR TREATING ARTHROLOGICAL DISEASES IN LYOPHILIZED FORM FOR INJECTIONS | 2024 | 
 | RU2827073C1 | 
| PEPTIDE NORMALIZING METABOLISM IN OSSEOUS AND CARTILAGE TISSUE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS USING | 2006 | 
 | RU2299741C1 | 
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 | 
 | RU2739746C1 | 
| TRANSDERMAL AGENT FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES, METHOD FOR PRODUCTION THEREOF AND COMBINED TRANSDERMAL PREPARATION FOR TREATING AND PREVENTING JOINT AND SOFT TISSUE DISEASES | 2013 | 
 | RU2582278C2 | 
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 | 
 | RU2739747C1 | 
| COMBINED AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 | 
 | RU2827069C1 | 
| AGENT POSSESSING ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIULCEROGENIC ACTION, ABILITY TO INHIBIT DEVELOPMENT OF DEGENERATIVE-DESTRUCTIVE PROCESSES OF TISSUES, WHICH IS 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM-4-ISOBUTYLPHENYLPROPANOATE | 2023 | 
 | RU2814495C1 | 
| COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS, OSTEOPOROSIS AND OSTEOARTHROSIS | 2013 | 
 | RU2521227C1 | 
Authors
Dates
2014-07-10—Published
2013-08-23—Filed